Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Poor Erythroid Engraftment”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07636486
What this trial is testing

Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies

Who this might be right for
LuspaterceptEpoetinPoor Erythroid Engraftment+1 more
Nanfang Hospital, Southern Medical University 90
Large-scale testing (Phase 3)Not Yet RecruitingNCT07539779
What this trial is testing

Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis

Who this might be right for
LuspaterceptPoor Erythroid EngraftmentHematological Malignancies+1 more
Nanfang Hospital, Southern Medical University 196